HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Primary effusion lymphoma with herpesvirus 8 DNA in patients coinfected with HIV and hepatitis C virus: a report of 2 cases.

Abstract
The primary effusion lymphoma (PEL), commonly described in patients with AIDS, is a unique subset of diffuse large cell lymphoma in which the malignant lymphocytes proliferate exclusively in serous cavities. The cytologic, immunophenotypic, and molecular features of PEL are presented from findings of 2 patients coinfected with HIV and hepatitis C virus who presented with abdominal pain. Abdominal radiography in both patients displayed marked peritoneal effusions. Cytomorphologic examination of peritoneal fluid revealed a malignant lymphoma in both. Their immunophenotypic expression was CD30 (Ki-1) and epithelial membrane antigen. Molecular analysis demonstrated human herpesvirus 8 DNA in both patients and bcl-2 oncogene rearrangement within the major breakpoint region of t(14;18) chromosome translocation in Case B only. Clinical correlation supports the current concept that PEL represents a primary HIV/AIDS-related lymphoma in effusion. Cytomorphologic examination of body cavity fluid serves as a tool for the initial diagnosis of PEL.
AuthorsS Hong, A E Krafft
JournalThe AIDS reader (AIDS Read) Vol. 11 Issue 8 Pg. 418-22 (Aug 2001) ISSN: 1053-0894 [Print] United States
PMID11570267 (Publication Type: Case Reports, Journal Article)
Chemical References
  • DNA, Viral
Topics
  • Adult
  • Ascitic Fluid (virology)
  • DNA, Viral (analysis)
  • Female
  • HIV Infections (complications, virology)
  • Hepatitis C (complications, virology)
  • Herpesviridae Infections (complications, virology)
  • Herpesvirus 8, Human (classification, genetics, immunology)
  • Humans
  • Immunophenotyping
  • Lymphoma, AIDS-Related (pathology, virology)
  • Male
  • Middle Aged

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: